Research Article
Prevalence of Insomnia among Pancreatic Cancer Patients following Pancreaticoduodenectomy
| | Variable | Value |
| | Age (years), | | | Gender (%) | Male | 27 (67.5%) | | Female | 13 (32.5%) | | BMI (kg/m2), | | | Smoking, (%) | 18 (45.0%) | | Alcohol consumption, (%) | 8 (20.0%) | | Caffeine intake, (%) | 18 (45.0%) | | Physical activity, (%) | 22 (55.0%) | | Comorbidities, (%) | Diabetes | 17 (42.5%) | | COPD | 2 (5.0%) | | CVD | 21 (52.5%) | | CKD | 4 (10.0%) | | Tumor characteristics, (%) | Grade | 1 | 7 (17.5%) | | 2 | 24 (60.0%) | | 3 | 8 (20.0%) | | 4 | 1 (2.5%) | | T stage | 1 | 7 (17.5%) | | 2 | 24 (60.0%) | | 3 | 8 (20.0%) | | 4 | 1 (2.5%) | | N stage | 0 | 16 (40.0%) | | 1 | 16 (40.0%) | | 2 | 8 (20.0%) | | M stage | 0 | 14 (35.0%) | | 1 | 26 (65.0%) | | Tumor size (cm), | | | Treatment regimen, (%) | Adjuvant chemotherapy | 22 (55.0%) | | Neoadjuvant chemotherapy | 2 (5.0%) | | Adjuvant radiotherapy | 1 (2.5%) | | Neoadjuvant radiotherapy | 0 (0.0%) | | No chemotherapy or radiotherapy | 15 (37.5%) | | All-cause mortality, (%) | 5 (12.5%) | | PSQI score, | | | ISI score, | |
|
|
BMI: body mass index; COPD: chronic obstructive pulmonary disease; CVD: cardiovascular disease; CKD: chronic kidney disease; PSQI: Pittsburgh Sleep Quality Index; ISI: Insomnia Severity Index.
|
